David Levy, Ph.D. Dave Abrams, Ph.D. & Patty Mabry, Ph.D. May 3, 2006

Slides:



Advertisements
Similar presentations
Terry R. Reid, MSW Quitline Funding & Budget Considerations.
Advertisements

2008 Johns Hopkins Bloomberg School of Public Health Setting Up a Smoking Cessation Clinic Sophia Chan PhD, MPH, RN, RSCN Department of Nursing Studies.
Low-Income and Blue-Collar Populations Elizabeth Barbeau, ScD, MPH Dana-Farber Cancer Institute Harvard School of Public Health.
Terry R. Reid, MSW Jan Schnellman, MEd Quitline Promotion: Creating Demand for Services.
Bronx BREATHES: Resources and Technical Assistance for Improved Tobacco Treatment Barbara Hart, MPA David Lounsbury, PhD Claudia Lechuga, MS Hal Strelnick,
1. Initiated Act 1 Fall Initiated Act Allocation of MSA Funds 3.
Intervention and Promotion Makes a Difference Tobacco cessation intervention by healthcare providers improves quit rates. Brief counseling is all that.
SETTING OUR COMPASS QuitlineNC: Partnering to Improve Tobacco Cessation in North Carolina.
The Greater Cleveland Cancer Prevention Research Collaborating Center Sue Flocke, PhD Case Western Reserve University October 29, 2014 This presentation.
Session 3: Assessing cost- effectiveness of population level interventions ARCH Technical Workshop Bali August 2014 Matt Glover Health Economics Research.
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
The Role of Quitlines in Comprehensive Tobacco Cessation: Where are We Now; Where are We Going; and How do We Get There? Tamatha Thomas-Haase, MPA Manager,
Program Evaluation in Public Health California’s Efforts to Reduce Tobacco Use David Hopkins Terry Pechacek.
SimSmoke: The effect of tobacco control policies on smoking prevalence and smoking-attributable deaths in 16 European Nations David Levy Pacific Institute.
Basics: 2As & R Clinical Intervention Artwork by Nancy Z. © 2010 American Aca0emy of Pediatrics (AAP) Children's Art Contest. Support for the 2010 AAP.
The Cost-Efficient Quitline: Considerations for Funders Christopher Anderson.
Addiction UNIT 4: PSYA4 Content The Psychology of Addictive Behaviour Models of Addictive Behaviour  Biological, cognitive and.
The Demand for and Supply of Cessation Products & Services Frank J. Chaloupka University of Illinois at Chicago.
Session 7—Presentation and Panel Discussion International Quitline Institute 2011 Conference October 11, 2011 Seattle, Washington National Center for Chronic.
Source: Massachusetts BRFSS Prepared by: Health Survey Program Using the BRFSS to Track Healthy People 2010 Objectives Highlights from the 2004 Massachusetts.
Tracey Strader, MSW, Executive Director Oklahoma Tobacco Settlement Endowment Trust The Oklahoma Tobacco Helpline.
Economics of Tobacco Use and Help-Seeking Behavior Bishwa Adhikari, Ph.D., Economist Office on Smoking and Health Centers for Disease Control and Prevention.
Demonstration of a Process- Outcome Link for Smoking Cessation Melissa M. Farmer, PhD 1,2 Elizabeth M. Yano, PhD 1,2 Brian S. Mittman, PhD 1,2 Scott E.
Changing the social climate of tobacco control in Mississippi: Collaborations Matter APHA 2002 Robert McMillen 1 Bonita Reinert 2 Julie Breen 1 SSRC 1.
Smoking Cessation Treatment Services in the United Kingdom Hayden McRobbie Barts and The London School of Medicine University of London.
TOBACCO CONTROL INITIATIVE HCSD Disease Management Program Quarterly Meeting April 26, 2005 Sarah Moody Thomas, PhD Statewide Clinical Lead.
1 David B. Abrams, Ph.D National Conference on Tobacco or Health Dec Boston The Centers for Behavioral & Preventive Medicine Brown Medical School,
Tobacco Use In Kansas Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
 2008 Johns Hopkins Bloomberg School of Public Health Evaluating Mass Media Anti-Smoking Campaigns Marc Boulay, PhD Center for Communication Programs.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Linking Together to.
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Modeling the Effects of Policies and Interventions on Adult Smoking Prevalence David Levy, Ph.D. Dave Abrams, Ph.D. & Patty Mabry, Ph.D. May 3, 2006.
TM Best Practices—2007 Centers for Disease Control and Prevention Deborah Houston McCall, MSPH, Program Consultant Program Services Branch Office on Smoking.
Why Quitlines Work Shu-Hong Zhu, Ph.D Gary Tedeschi, Ph.D. University of California, San Diego NAQC Annual Membership Meeting, Chicago May 2-3, 2005, Chicago.
Citizens of Harvestland Against Tobacco (CHAT) Coalition Harvestland, Missouri Teaming Up To End Tobacco Use.
 2007 Johns Hopkins Bloomberg School of Public Health Section C Case Study: Ireland.
Helping providers connect patients to quitline support.
Enhancing Tobacco Cessation Treatment for the Medicaid Population Linda Bailey, Center for Tobacco Cessation Helen Halpin, University of California at.
Comprehensive Tobacco Action Group Summary December 16, 2005.
The ‘impossible dream’ Implementing a No Smoking Policy on hospital grounds - Why preventing smoking in the workplace requires more than just policy Trina.
The Role of Epidemiological Surveillance in Tobacco Control Yang Gonghuan China CDC/PUMC.
SMOKING CESSATION: THE MINIMAL CONTACT INTERVENTION.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
INFLUENCE OF TOBACCO AND PHARMACEUTICAL INDUSTRIES ON TOBACCO CONTROL PROGRAMS John P. Pierce, Wael Al-Delaimy Karen Messer, Dennis Trinidad & UCSD Tobacco.
1 Effects on smoking cessation of a national strategy to maximise NRT usage: the UK experience Robert West University College London WCTOH July 2006 Washington.
The Impact of Smoking Cessation Interventions by Multiple Health Professionals Lawrence An, MD 1 ; Steven Foldes, PhD 2 ; Nina Alesci, PhD 1 ; Patricia.
CHAPTER 13: THE NUTS AND BOLTS OF QUASI- EXPERIMENTS.
Presenter Disclosures
Washington’s Tobacco and Vapor Product Prevention and Control Program House Health Care & Wellness Committee January 20, 2017 Frances Limtiaco, Program.
Anita R. Webb, PhD JPS Family Medicine Residency
screening, brief intervention and referral to treatment
Assistant professor Family Medicine - Suez Canal University
Stop Smoking Wales support Daniel Clayton – Health Promotion Practitioner Insert name of presentation on Master Slide V: 01/2012.
Nick Wilson* (Otago University, Wellington)
Tim McAfee, M.D., M.P.H. Director, CDC Office on Smoking and Health
QuitlineNC Funding.
The Burden of Tobacco Use
Current Evidence-Based Cessation Treatments: Efficacy and Critical Ingredients Saul Shiffman.
Towards a Smokefree Generation: A Tobacco Control Plan for England South West Clinical Senate 21 September 2017
Value of Pharmaceuticals in Managed Care Pharmacy
ABCs of Behavioral Support
Preventing Suicide in the Workplace
Age inequity and Smoking Cessation
Should we now focus on 'the endgame' for tobacco control in the UK?
Smoking Cessation Smoke Signals.
Developing a system of care
Value of Pharmaceuticals in Managed Care Pharmacy
Caring for the smoking asthmatic patient
Presentation transcript:

David Levy, Ph.D. Dave Abrams, Ph.D. & Patty Mabry, Ph.D. May 3, 2006 Modeling the Effects of Policies and Interventions on Adult Smoking Prevalence David Levy, Ph.D. Dave Abrams, Ph.D. & Patty Mabry, Ph.D. May 3, 2006

Modeling: What is it good for? Modeling is a great heuristic tool Modeling helps reveal relationships by organizing the channels of influence and by making assumptions explicit The formalization of relationships and assumptions through modeling usually proves more robust than the informal approach of relying on intuition alone. As such, models are useful for evaluating alternative futures

Two Types of Models, for Different Purposes Data-driven models: Are derived from data/studies, e.g., how effective past policies have been in affecting smoking rates Useful in understanding and predicting how changes in inputs lead to changes in outputs, e.g., how individual policies and combinations of policies might impact future smoking prevalence Speculative or “what if” models: Are not data-driven, but are based on specific assumptions about inputs, e.g., allow for changes in the factors that drive smoking cessation in order to see what would happen to smoking prevalence if this could be done. Are useful for stimulating out-of-the-box thinking and have heuristic value. We will examine what it would take to reach Healthy People 2010 goals and other targets for smoking prevalence.

Other info about today’s models All models are adult focused Prevention of smoking uptake is not considered as a policy or intervention, as it will have a small influence on adult smoking prevalence in the next 15 years (Levy, Cummings et al (2000). All policies/interventions are directed at adults aged 18 and over Begin with a status quo model of future trends (starting in 2006) Assumes that policies stay at their 2006 levels in future years Assumes Cessation from and Relapse back to smoking occurs at a constant rate over time, based on current rates. Assumes New smokers take up smoking at a constant rate, based on recent data New smokers and relapse back to smoking the number of new smokers taking up smoking each year is assumed to remain constant throughout the term of the model. In reality, if smoking prevalence were to drop it is likely that the number of new smokers taking up smoking would also drop, at least by a small amount, due to changes in social norms Relapse back to smoking is assumed to occur in all models at a rate based on current relapse rates. However, where expressly noted in speculative models, we have made assumptions about reducing the relapse rates

Other info about today’s models-2 Policy/Interventions Policies go into effect in the year 2007 and are sustained through the year 2020 Policies affect cessation rates through quit attempts, quit success, and/or relapse in the first year (long-term abstinence), which is then translated into percentage changes in prevalence Takes into account the past level of policies/interventions

Outline for Today’s Talk 3-shot Model (speculative, “what if” scenarios) Traditional Policies (taxes, clean air, media) Model (data driven) Cessation Treatment Policies Model (data-driven) Full Throttle Model (combination data-driven & speculation) Discussion

3-Shot Model This model presents a series of “what if” scenarios. This is a speculative model. What if we could… increase the number of smokers making quit attempts? increase the number of smokers who use evidence-based treatments? Increase long term abstinence across all forms of treatment?

One-Shot Model: Quit Attempts What if we could… Increase the number of people making quit attempts by 50%: from 40% of smokers to 60% of smokers annually? Increase the number of people making quit attempts by 100%: from 40% of smokers to 80% of smokers annually.

One-shot Model - "What if we could increase...?" Quit Attempts Status Quo 17.9% HP 2010 Goal: 12% 60% of smokers make quit attempt: 2020 prev = 14.6% 80% smokers make quit attempt: 2020 prev = 12.3%

One-Shot Model: Double the Use of Evidence Based Treatment Of those making a quit attempt in the last year, what if we could double the use of EB treatments such that… from 22% to 44% who use FDA approved pharmacotherapy alone, from 2% to 4% who use behavioral therapy alone, and from 4% to 8% who use a combination of evidence based pharmacotherapy and behavioral therapy.

Two-Shot Model: Quit Attempts & Evidence Based Treatment Use What if … the number of people who make a quit attempt is increased 100% over current levels (from 40% to 80% of smokers in a given year) *AND* we double the number of people who use evidence based treatments (44% use PT, 4% use BT, and 8% use PT +BT)

Two-shot Model - "What if we could increase Two-shot Model - "What if we could increase...?" Quit Attempts & Use of Evidence Based Tx Status Quo 17.9% HP 2010 Goal: 12% 2017 Double the # smokers who use evidence based tx: 2020 prev = 16.0% QA 80% + 2X EB tx: 2020 prev = 10.7%

One-Shot Model: Improve Long-Term Abstinence What if … The number of people who stay quit after a quit attempt is increased by 50% (or 100%) for all forms of treatment? from 7.5% success to 11.25% (or 15%) success for unassisted quitters from 15% success to 22.5% (or 30%) success for those using evidence based pharmacotherapy only from 15% success to 22.5% (or 30%) success for those using evidence based behavioral therapy only from 25% success to 37.5% (or 50%) success for those using evidence-based pharmacotherapy combined with evidence-based behavioral therapy

Three-Shot Model: Quit Attempts, Evidence-Based Treatment Use & Long-Term Abstinence “What if”… The number of people who make a quit attempt is increased 100% over current levels (from 40% to 80% of smokers in a given year) *AND* Twice as many people use evidence based treatments (44% use PT, 4% use BT, and 8% use PT +BT) The number of people who achieve long-term abstinence is increased by 50% or 100% for all forms of treatment.

3-Shot Model - "What if we could increase 3-Shot Model - "What if we could increase...?" Quit Attempts, E-B Tx, Long-term Abstinence Status Quo 17.9% 2013 HP 2010 Goal: 12% 2011 50% of quitters achieve long term abstinence: 2020 prev = 14.6% 100% of quitters achieve LTA: 2020 prev = 12.3% 3-shot - QA 80% + 2X EB tx + LTA 50%: 2020 prev = 8.1% 3-shot - QA 80% + 2X EB tx + LTA 100%: 2020 prev = 6.6%

Traditional Policies Model: Tax Increase, Clean Indoor Air, Media We individually consider the following policies: Increase taxes by $2.00 per pack in Yr 1 Enact nationwide clean indoor air laws Run media campaigns to promote quitting and use of evidence-based treatments across all years (2007-2020) Will then combine all of the above policies simultaneously Based on previous studies of their effect on quitting behavior and prevalence. Modeled through quit attempts, with biggest effect in the first year

Traditional Tobacco Control Policies Model Status Quo 17.9% HP 2010 Goal: 12% Tax increase to $2.00 per pack: 2020 prev = 16.4% Clean Indoor Air laws: 2020 prev = 17.0% Media campaigns: 2020 prev = 17.2% All 3 traditional policies combined: 2020 prev = 15.0%

Cessation Policies Model (adult) We individually consider the following interventions: Complete financial access to evidence based treatment (pharmacotherapy/behavioral tx) Proactive quitlines – free to all Web-based treatment – free to all Brief interventions – ask, advise, assist, arrange for every patient in every health care setting We then combine, in stepwise fashion, all of the above Based on previous studies of their effect on quitting behavior and prevalence. Modeled through quit attempts and quit success, with biggest effect in the first year All policies are for adults 18 and over.

Cessation Policies Model (adult) Status Quo 17.9% HP 2010 Goal: 12% Complete financial access to EB tx: prev 2020 16.9% Free proactive quitlines: 2020 prev = 17.7% Free P-QL + free NRT: 2020 prev = 17.2% Complete financial access + P-QL + Free NRT: 2020 prev = 16.5% Free web-based tx: 2020 prev = 17.6% Complete financial access + P-QL + NRT + free web tx: 2020 prev = 16.1% Brief intervention at every health care visit: 2020 prev = 17.4% All 5 cessation policies combined: 2020 prev = 15.8%

Full Throttle Model: Data-driven + speculation Traditional tobacco control policies (all 3) *AND* Cessation Policies (adult, all 5) “What if we could…”: Increase Long-Term Abstinence Rates by 50% or 100%

Traditional Policies, Adult Cessation Policies, Increase LTA Full Throttle Model: Traditional Policies, Adult Cessation Policies, Increase LTA Status Quo 17.9% 2015 HP 2010 Goal: 12% 2012 $2 Taxes + Clean Indoor Air laws + Media: prev 2020 15.0% All 5 cessation policies: prev 2020 15.8% All 3 traditional policies + all 5 cessation policies: prev 2020 13.3% All 8 policies + increase LTA by 50%: prev 2020 9.7% All 8 policies + increase LTA by 100%: prev 2020 7.5%

Summary Traditional policies alone, even if implemented today nationwide won’t get us to HP 2010 goals for prevalence…even by 2020! But there is hope, if we can make a breakthrough and act immediately: 3-shot model: dramatic increase in QA, EB tx, LTA could get us there by 2011 and to 6.6% by 2020 Full throttle model: traditional and cessation policies combined with increasing LTA could get us there by 2012 and to 7.5% by 2020

END

3-shot Model - Everything Quit Attempts, Evidence-Based Tx, LTA 50/100 Status Quo 17.9% HP 2010 Goal: 12% 2010 60% of smokers make quit attempt: 2020 prev = 14.6% 80% smokers make quit attempt: 2020 prev = 12.3% Double the # smokers who use evidence based tx: 2020 prev = 16.0% QA 80% + 2X EB tx: 2020 prev = 10.7% 50% of quitters achieve long term abstinence: 2020 prev = 14.6% 100% of quitters achieve LTA: 2020 prev = 12.3% 3-shot - QA 80% + 2X EB tx + LTA 50%: 2020 prev = 8.1% 3-shot - QA 80% + 2X EB tx + LTA 100%: 2020 prev = 6.6%